These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7789083

  • 1. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 3. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 30; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].
    Michelini S, Micci A, Failla A, Grechi G, Iantaffi A.
    Minerva Cardioangiol; 1996 Nov 30; 44(1-2):33-7. PubMed ID: 8767620
    [Abstract] [Full Text] [Related]

  • 5. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov 30; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 6. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr 30; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 7. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S, Bach R, Schieffer H.
    Int Angiol; 1992 Apr 30; 11(3):204-10. PubMed ID: 1460355
    [Abstract] [Full Text] [Related]

  • 8. Defibrotide and peripheral obliterative arterial disease: preliminary data.
    Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, Lechi A.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov 30; 27(11):526-9. PubMed ID: 2533180
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Trübestein G, Trübestein R, Duong QD.
    Angiology; 1981 Oct 30; 32(10):705-10. PubMed ID: 7034591
    [Abstract] [Full Text] [Related]

  • 10. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989 Oct 30; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 11. Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease.
    Milio G, Cospite V, Cospite M.
    Minerva Cardioangiol; 2003 Jun 30; 51(3):311-6. PubMed ID: 12867883
    [Abstract] [Full Text] [Related]

  • 12. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Jun 30; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 13. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A, Fareed J, Sabbá C, Albano O, Allegra C, Carlizza A, Binaghi F, Fronteddu F, Del Guercio R, Arpaia MR.
    Semin Thromb Hemost; 1991 Nov 30; 17 Suppl 2():228-34. PubMed ID: 1948094
    [Abstract] [Full Text] [Related]

  • 15. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 30; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F, Capecchi PL, Acciavatti A, Petri S, de Lalla A, Cati G, Colafati M, Di Perri T.
    Clin Hemorheol Microcirc; 1997 Aug 30; 17(1):73-84. PubMed ID: 9181761
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M.
    Angiology; 1994 Jul 30; 45(7):647-53. PubMed ID: 8024164
    [Abstract] [Full Text] [Related]

  • 18. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease.
    Sabbá C, Zupo V, Dina F, Nazzari M, Albano O.
    Int J Clin Pharmacol Ther Toxicol; 1988 May 30; 26(5):249-52. PubMed ID: 3045026
    [Abstract] [Full Text] [Related]

  • 19. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 20. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.